X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4047) 4047
Book Chapter (57) 57
Newspaper Article (56) 56
Publication (6) 6
Book / eBook (3) 3
Conference Proceeding (3) 3
Dissertation (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3211) 3211
male (2143) 2143
female (2110) 2110
middle aged (1932) 1932
aged (1639) 1639
adult (1466) 1466
surgery (1390) 1390
neuroendocrine tumors (1321) 1321
prognosis (1174) 1174
oncology (1142) 1142
tumors (1125) 1125
cancer (1040) 1040
retrospective studies (921) 921
survival (790) 790
metastasis (752) 752
neuroendocrine tumors - pathology (745) 745
aged, 80 and over (744) 744
neuroendocrine tumors - mortality (739) 739
treatment outcome (726) 726
management (638) 638
survival rate (627) 627
neoplasm staging (569) 569
pancreatic neoplasms - pathology (558) 558
neuroendocrine tumors - surgery (554) 554
medicine & public health (529) 529
diagnosis (521) 521
pancreatic neoplasms - surgery (476) 476
survival analysis (475) 475
chemotherapy (459) 459
pancreatic neoplasms - mortality (459) 459
analysis (451) 451
carcinoma (441) 441
liver neoplasms - secondary (438) 438
gastroenterology & hepatology (434) 434
pancreas (414) 414
follow-up studies (411) 411
endocrinology & metabolism (406) 406
pathology (405) 405
patients (403) 403
immunohistochemistry (399) 399
young adult (394) 394
prognostic-factors (369) 369
care and treatment (364) 364
adolescent (362) 362
metastases (352) 352
endocrine tumors (348) 348
disease-free survival (347) 347
abridged index medicus (336) 336
kaplan-meier estimate (332) 332
mortality (330) 330
resection (329) 329
risk factors (329) 329
epidemiology (327) 327
carcinoma, neuroendocrine - pathology (322) 322
neuroendocrine tumor (316) 316
medical prognosis (311) 311
neoplasms (308) 308
neuroendocrine (300) 300
carcinoma, neuroendocrine - mortality (294) 294
health aspects (292) 292
neuroendocrine tumors - diagnosis (287) 287
liver (286) 286
research (279) 279
neuroendocrine tumors - therapy (276) 276
classification (274) 274
carcinoid-tumors (266) 266
expression (261) 261
liver metastases (239) 239
liver neoplasms - mortality (238) 238
liver neoplasms - surgery (235) 235
neuroendocrine tumors - secondary (235) 235
adenocarcinoma (229) 229
animals (227) 227
experience (220) 220
lung neoplasms - pathology (219) 219
neuroendocrine carcinoma (212) 212
pancreatic neoplasms - diagnosis (212) 212
lung neoplasms - mortality (208) 208
lymphatic metastasis (208) 208
carcinoid (201) 201
time factors (201) 201
multivariate analysis (198) 198
proportional hazards models (194) 194
neoplasm metastasis (189) 189
neoplasm grading (188) 188
carcinoid tumor - mortality (186) 186
carcinoid tumor - pathology (184) 184
gastroenterology (174) 174
neuroendocrine tumors - drug therapy (174) 174
combined modality therapy (171) 171
therapy (171) 171
carcinoma, neuroendocrine - surgery (170) 170
pancreatic cancer (170) 170
neuroendocrine differentiation (167) 167
medical research (164) 164
antineoplastic agents - therapeutic use (163) 163
mutation (162) 162
disease progression (156) 156
enets consensus guidelines (156) 156
lung cancer (156) 156
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4072) 4072
German (53) 53
Spanish (25) 25
French (22) 22
Chinese (17) 17
Portuguese (13) 13
Hungarian (3) 3
Italian (3) 3
Japanese (3) 3
Korean (3) 3
Polish (3) 3
Turkish (2) 2
Arabic (1) 1
Czech (1) 1
Greek (1) 1
Icelandic (1) 1
Latvian (1) 1
Norwegian (1) 1
Russian (1) 1
Serbian (1) 1
Slovak (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Medicine, ISSN 2045-7634, 10/2017, Volume 6, Issue 10, pp. 2347 - 2356
...). We examined the prognostic association of tumor PD‐L1 positivity using the log‐rank test as well as Cox proportional hazards regression models to calculate the hazard ratio (HR) for mortality. Programmed death... 
lung cancer | small cell carcinoma | Immune checkpoint | LCNEC | outcome | PD‐L1 | PD-L1 | PROGNOSIS | LANDSCAPE | ADENOCARCINOMA | CANCER | LIGAND 1 EXPRESSION | ONCOLOGY | SMALL-CELL | BLOCKADE | NIVOLUMAB | ASSOCIATION | IPILIMUMAB | Immunohistochemistry | Prognosis | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Biomarkers, Tumor | Small Cell Lung Carcinoma - drug therapy | Neoplasm Metastasis | Neoplasm Grading | Adult | Female | Lung Neoplasms - genetics | Neuroendocrine Tumors - pathology | Gene Expression | Kaplan-Meier Estimate | Lung Neoplasms - therapy | Small Cell Lung Carcinoma - genetics | Tumor Burden | B7-H1 Antigen - genetics | Neuroendocrine Tumors - genetics | B7-H1 Antigen - metabolism | Small Cell Lung Carcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neuroendocrine Tumors - mortality | Small Cell Lung Carcinoma - mortality | Aged | Neuroendocrine Tumors - therapy | Neoplasm Staging | Lung cancer | Analysis | Immunotherapy | Mortality | T cells | Health aspects | Tumors | Small cell lung carcinoma | Tumor cells | Lymphocytes T | Lung carcinoma | Regression analysis | Immunosuppression | Ligands | Health risk assessment | Movement disorders | Apoptosis | Neuroendocrine tumors
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10022, pp. 968 - 977
Journal Article
Endocrinology and metabolism clinics of North America, ISSN 0889-8529, 03/2011, Volume 40, Issue 1, pp. 1 - 18
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 364, Issue 6, pp. 514 - 523
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2008, Volume 26, Issue 13, pp. 2124 - 2130
Journal Article
Journal Article
BMC cancer, ISSN 1471-2407, 2019, Volume 19, Issue 1, pp. 334 - 10
Background: Our aim was to determine the epidemiology and recent changes in the trends of non-functional pancreatic neuroendocrine tumours (NF-pNETs... 
SURVIVAL | SYSTEM | DIAGNOSIS | SCORE | PROGNOSTIC-FACTORS | NEOPLASMS | RESECTION | Incidence-based mortality | Non-functional pancreatic neuroendocrine tumours | Epidemiology | HEPATOCELLULAR-CARCINOMA | APC | ONCOLOGY | SEER | Medicine, Experimental | Medical research | Analysis | Risk factors | Tumors | Incidence-based mortality, APC, SEER
Journal Article